KP Tissue Inc. (KPTSF) Q2 2023 Earnings Call Transcript


KP Tissue Inc. (OTCPK:KPTSF) Q2 2023 Earnings Call August 10, 2023 8:30 AM ET

Company Participants

Mike Baldesarra – Director, Investor Relations

Dino Bianco – Chief Executive Officer

Mark Holbrook – Chief Financial Officer

Conference Call Participants

Hamir Patel – CIBC Capital Markets

Kasia Kopytek – TD Securities

Paul Quinn – RBC Capital

Operator

Good morning ladies and gentlemen. Thank you for standing by. Welcome to the KP Tissue Second Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] Before turning the meeting over to management, I would like to remind everyone that this conference call is being recorded today, Thursday, August 10, 2023.

I would now like to turn the call over to Mike Baldesarra, Director, Investor Relations. Please go ahead.

Mike Baldesarra

Thank you, operator, and good morning, ladies and gentlemen. My name is Mike Baldesarra, I’m the Director of Investor Relations of KP Tissue Inc. The purpose of the conference call is to review the financial results of the second quarter of 2023 for Kruger Products Inc., which I’ll refer to as Kruger Products going forward.

With me this morning is Dino Bianco, the Chief Executive Officer of KP Tissue and Kruger Products; and Mark Holbrook, the Chief Financial Officer of KP Tissue and Kruger Products.

The following discussions and responses to questions contain forward-looking statements concerning the company’s activities. Forward-Looking statements involve known and unknown risks and uncertainties, which could cause the company’s actual results to differ materially from those in the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The company does not undertake to update these forward-looking statements except if required by applicable laws. There’s a page at the beginning of the written presentation which contains the usual legal



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *